Phathom Pharmaceuticals shares soar on FDA exclusivity grant
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Guggenheim on Phathom Pharmaceuticals (PHAT): 'Our NPV analysis suggests fair value in the $12-14 range'
June 6, 2025 1:46 PM EDTGuggenheim analyst Yatin Suneja reiterated a Buy rating and $12.00 price target on Phathom Pharmaceuticals (NASDAQ: PHAT).
The analyst comments "Recall that in Dec 2024, PHAT submitted a Citizen Petition (CP) to the FDA to formally request correction to the Orange Book listings for 10 mg... More
Phathom Pharmaceuticals (PHAT) PT Raised to $29 at Cantor Fitzgerald
June 6, 2025 1:16 PM EDTCantor Fitzgerald analyst Kristen Kluska raised the price target on Phathom Pharmaceuticals (NASDAQ: PHAT) to $29.00 (from $23.00) while maintaining a Overweight rating.
... MoreStifel Reiterates Buy Rating on Phathom (PHAT), PT $28, 'We leave our model unchanged, as our view reflected full 10-year exclusivity'
June 6, 2025 12:48 PM EDTStifel analyst Annabel Samimy reiterated a Buy rating and $28.00 price target on Phathom Pharmaceuticals (NASDAQ: PHAT).
The analyst comments "Voquezna Granted CP and Officially Gains 10-Year Exclusivity, Extending to 2032: Recall, last December PHAT filed a citizens petition/ CP to proactively nudge the FDA to update the Orange... More
